Kombiglyze – Emerging Litigation

Kombiglyze XR is a new drug for type-2 diabetes that combines saxagliptin with metformin. Although it has only been on the market since 2010, it has already sparked a warning from the FDA regarding pre-cancerous pancreatic tumors, hospitalization for heart failure, and death.


Let Our MDs Evaluate Your Mass Tort Cases
Our 100+ MDs undertake Threshold Evaluations and Plaintiff Fact Sheets for $35/hr – a billable expense